| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |